SETDB1 and myelodysplastic syndrome: The disruption of SETDB1 in AML cell lines triggers a type-I IFN antiviral response by desilencing both the LTR and non-LTR elements, indicating that the evasion of innate immune sensing of EREs possibly underlies the poor prognostic impact of SETDB1 alterations in AML and MDS (51).